Philippe Couttet
Novartis (Switzerland)(CH)Novartis (China)(CN)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Fibroblast Growth Factor Research, Kruppel-like factors research, MicroRNA in disease regulation, Cancer-related molecular mechanisms research
Most-Cited Works
- → Requirement of bic/microRNA-155 for Normal Immune Function(2007)1,838 cited
- → The landscape of histone modifications across 1% of the human genome in five human cell lines(2007)444 cited
- → Messenger RNA deadenylylation precedes decapping in mammalian cells(1997)206 cited
- → Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4(2020)110 cited
- → FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer(2019)100 cited
- → Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment(2012)94 cited